Hologic (HOLX) Stock Price, News & Analysis

Company Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Key Stats

• Today's Range: $70.36 to $71.95
• 50-Day Range: $70.76 to $83.72
• 52-Week Range: $70.36 to $84.67
• Volume: 8.56 million shs
• Average Volume: 1.67 million shs
• Market Capitalization: $16.26 billion
• P/E Ratio: 21.52
• Dividend Yield: N/A
• Price Target: $89.50
• Consensus Rating: Moderate Buy

Hologic Stock Analysis - MarketRank™

Hologic scored higher than 94% of companies evaluated by MarketBeat, and ranked 36th out of 947 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Hologic has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 8 buy ratings, 6 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Hologic has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.11%

Earnings Growth

Earnings for Hologic are expected to grow by 9.11% in the coming year, from $4.28 to $4.67 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hologic is 21.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 115.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hologic is 21.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.08.

Price to Earnings Growth Ratio

Hologic has a PEG Ratio of 2.38. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Hologic has a P/B Ratio of 3.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.75% of the float of Hologic has been sold short.

Short Interest Ratio / Days to Cover

Hologic has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Hologic has recently increased by 33.99%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hologic does not currently pay a dividend.

Dividend Growth

Hologic does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.3 / 5
• Environmental Score: -1.50

Percentage of Shares Shorted

2.75% of the float of Hologic has been sold short.

Short Interest Ratio / Days to Cover

Hologic has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Hologic has recently increased by 33.99%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.75

News Sentiment

Hologic has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for Hologic this week, compared to 10 articles on an average week.

MarketBeat Follows

Only 3 people have added Hologic to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Hologic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,897,507.00 in company stock.

Percentage Held by Insiders

Only 1.75% of the stock of Hologic is held by insiders.

Percentage Held by Institutions

94.73% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HOLX Stock Analysis - Frequently Asked Questions

How have HOLX shares performed this year?

Hologic's stock was trading at $71.45 at the beginning of 2024. Since then, HOLX shares have increased by 0.3% and is now trading at $71.65.
View the best growth stocks for 2024 here.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) issued its earnings results on Monday, November, 4th. The medical equipment provider reported $1.01 EPS for the quarter, meeting the consensus estimate of $1.01. Hologic's revenue was up 4.5% on a year-over-year basis.
Read the conference call transcript.

Does Hologic have any subsidiaries?

Hologic subsidiaries include these companies: Bolder Surgical, Mobidiag Oy, Diagenode SA, Biotheranostics Inc, Somatex Medical Technologies GmbH, Acessa Health, Health Beacons Inc, and others.

Who are Hologic's major shareholders?

Top institutional shareholders of Hologic include State Street Corp (4.48%), Geode Capital Management LLC (2.41%), FMR LLC (2.40%) and Victory Capital Management Inc. (2.11%). Insiders that own company stock include Stephen P Macmillan, John M Griffin, Karleen Marie Oberton, Jan Verstreken, Scott T Garrett, Christiana Stamoulis, Essex D Mitchell, Benjamin Jordan Cohn, Brandon Schnittker, Charles J Dockendorff and Sean S Daugherty.
View institutional ownership trends.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hologic investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 11/04/2024
• Today: 12/20/2024
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: X - ray apparatus & tubes
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:HOLX
• CUSIP: 43644010
• CIK: 859737
• Web: www.hologic.com
• Phone: (508) 263-2900
• Fax: 781-890-8031
• Employees: 7,063
• Year Founded: 1985

Price Target and Rating

• Average Stock Price Target: $89.50
• High Stock Price Target: $95.00
• Low Stock Price Target: $82.00
• Potential Upside/Downside: +24.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 15 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.33
• Trailing P/E Ratio: 21.52
• Forward P/E Ratio: 16.74
• P/E Growth: 2.38
• Net Income: $789.50 million
• Net Margins: 19.59%
• Pretax Margin: 21.47%
• Return on Equity: 19.79%
• Return on Assets: 11.00%

Debt

• Debt-to-Equity Ratio: 0.49
• Current Ratio: 3.69
• Quick Ratio: 3.03

Sales & Book Value

• Annual Sales: $4.03 billion
• Price / Sales: 4.03
• Cash Flow: $5.22 per share
• Price / Cash Flow: 13.73
• Book Value: $22.09 per share
• Price / Book: 3.24

Miscellaneous

• Outstanding Shares: 226,941,000
• Free Float: 222,970,000
• Market Cap: $16.26 billion
• Optionable: Optionable
• Beta: 0.96